OxySure Therapeutics, Inc. (OXYS) 股票表現
查看OxySure Therapeutics, Inc.的財務表現,包括市值、價格變動百分比、本益比,以及歷史和當前股價。
前收盤價0.03
52週高點0.03
打開0.03
52週低點0.03
資金流向0.00%
本益比0%
T/O0.00b
市淨率0%
離職率0.00%
市值0.00b
股息0
總股數0.36b
股息殖利率0%
批量大小1
OxySure Therapeutics, Inc.公司簡介
OxySure Systems, Inc. is a medical technology company that focuses on the design, manufacture and distribution of specialty medical and respiratory solutions. The company pioneered the "oxygen from powder" technology: a safe and easy to use solution to produce medically pure (USP) oxygen from two, dry, inert powders. The company owns numerous issued and pending patents on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other public settings. In addition to oxygen products for public/lay responder usage, OxySure also markets emergency medical solutions including AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and HeartSine), Quickclot Bleeding Control solutions, resuscitation products and pulse oximetry products.